A Michael Lincoff Selected Research

A Michael Lincoff Research Topics

Disease

65	Hemorrhage 01/2020 - 05/2002
61	Myocardial Infarction 01/2021 - 05/2002
49	Acute Coronary Syndrome 01/2020 - 08/2003
22	Thrombosis (Thrombus) 01/2021 - 05/2002
20	ST Elevation Myocardial Infarction 01/2022 - 07/2002
20	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2002
20	Stroke (Strokes) 01/2021 - 03/2006
18	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 08/2003
16	Type 2 Diabetes Mellitus (MODY) 05/2021 - 09/2007
16	Ischemia 01/2019 - 07/2002
12	Unstable Angina 10/2020 - 06/2003
9	Inflammation (Inflammations) 11/2020 - 03/2002
9	Vascular Diseases (Vascular Disease) 10/2020 - 09/2007
9	Diabetes Mellitus 01/2020 - 06/2004
7	Infarction (Infarctions) 11/2020 - 07/2002
7	Heart Failure 11/2020 - 08/2003
7	Anemia 12/2014 - 07/2004
6	Coronary Disease (Coronary Heart Disease) 01/2018 - 05/2002
6	Hyperplasia 04/2006 - 04/2002
5	Rheumatoid Arthritis 01/2018 - 04/2009
5	Osteoarthritis 01/2018 - 04/2009
5	Atherosclerosis 01/2014 - 08/2005
5	Vascular System Injuries 08/2005 - 10/2002
4	Chronic Renal Insufficiency 01/2018 - 05/2002
4	Thrombocytopenia (Thrombopenia) 06/2008 - 11/2004
3	Peripheral Arterial Disease 01/2021 - 10/2006
3	Atherosclerotic Plaque (Atheroma) 01/2021 - 05/2002
3	Arthritis (Polyarthritis) 11/2017 - 04/2009
3	Hypersensitivity (Allergy) 12/2016 - 06/2008
3	Non-ST Elevated Myocardial Infarction 02/2015 - 08/2003
3	Renal Insufficiency (Renal Failure) 02/2009 - 04/2002
2	Disease Progression 01/2021 - 04/2008
2	Death (Near-Death Experience) 01/2021 - 01/2021
2	Hypertriglyceridemia 12/2020 - 10/2018
2	Heart Diseases (Heart Disease) 11/2020 - 03/2008
2	Hyperglycemia 11/2020 - 01/2010
2	Hypertension (High Blood Pressure) 11/2017 - 04/2002

Drug/Important Bio-Agent (IBA)

45	bivalirudin (Angiomax)FDA Link 01/2018 - 05/2002
43	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 05/2002
28	Glycoproteins (Glycoprotein)IBA 01/2018 - 07/2002
15	Platelet Membrane Glycoprotein IIbIBA 02/2016 - 02/2003
13	Clopidogrel (Plavix)FDA Link 11/2014 - 07/2006
12	Abciximab (ReoPro)FDA Link 10/2007 - 04/2002
11	aleglitazarIBA 01/2020 - 07/2009
9	Pharmaceutical PreparationsIBA 01/2021 - 06/2002
9	evacetrapibIBA 10/2020 - 12/2015
9	AnticoagulantsIBA 01/2020 - 05/2002
9	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016 - 07/2006
8	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020 - 07/2009
7	Insulin (Novolin)FDA Link 01/2021 - 04/2008
7	LipidsIBA 01/2021 - 11/2003
7	omega-Chloroacetophenone (Mace)IBA 01/2021 - 02/2011
7	Cholesterol Ester Transfer ProteinsIBA 01/2020 - 12/2015
7	AntithrombinsIBA 05/2008 - 05/2002
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 10/2018
6	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2003
6	Celecoxib (Celebrex)FDA Link 01/2018 - 01/2005
6	Enoxaparin (Lovenox)FDA LinkGeneric 09/2008 - 01/2003
5	Naproxen (Naprosyn)FDA LinkGeneric 01/2018 - 04/2009
5	Ibuprofen (Motrin)FDA LinkGeneric 01/2018 - 04/2009
5	Platelet Membrane GlycoproteinsIBA 02/2008 - 11/2002
4	CholesterolIBA 01/2021 - 08/2014
4	C-Reactive ProteinIBA 10/2020 - 02/2011
4	Biomarkers (Surrogate Marker)IBA 01/2017 - 03/2007
4	Pioglitazone (Actos)FDA Link 11/2014 - 09/2007
4	MB Form Creatine KinaseIBA 10/2014 - 03/2005
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2008 - 11/2006
4	Eptifibatide (Integrilin)FDA Link 02/2008 - 01/2003
4	reteplase FDA Link 10/2007 - 07/2002
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021 - 10/2016
3	CSL112IBA 01/2021 - 10/2016
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2017 - 04/2009
3	AntibodiesIBA 12/2016 - 02/2007
3	CreatinineIBA 06/2011 - 10/2003
3	cangrelorIBA 12/2009 - 02/2003
3	P-SelectinIBA 08/2005 - 07/2002
3	LigandsIBA 05/2003 - 07/2002
2	Corn Oil (Oil, Corn)IBA 05/2021 - 12/2020
2	oxidized low density lipoproteinIBA 01/2021 - 01/2019
2	HDL CholesterolIBA 12/2020 - 01/2019
2	Lipoprotein(a)IBA 10/2020 - 01/2020
2	varespladibIBA 01/2019 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2002
2	Triglycerides (Triacylglycerol)IBA 10/2018 - 01/2010
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 09/2013
2	RB 006IBA 12/2016 - 01/2016
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2016 - 07/2011
2	Creatine Kinase (Creatine Phosphokinase)IBA 10/2014 - 11/2008
2	Adenosine Diphosphate (ADP)IBA 11/2012 - 02/2003

Therapy/Procedure

60	Therapeutics 01/2021 - 01/2002
51	Percutaneous Coronary Intervention 01/2022 - 05/2002
23	Stents 01/2021 - 04/2002
10	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2018 - 12/2002
8	Drug-Eluting Stents 01/2021 - 07/2006
8	Thrombolytic Therapy 10/2014 - 11/2002
6	Blood Transfusion (Blood Transfusions) 06/2011 - 01/2003
4	Drug Therapy (Chemotherapy) 01/2021 - 02/2009
4	Secondary Prevention 10/2020 - 11/2003
4	Glycemic Control 01/2020 - 09/2007
2	Patient Readmission 10/2017 - 01/2012